Abstract:Many studies have shown a close association between Nogo-B and inflammation-related diseases. However, uncertainty does exist, regarding Nogo-B function in the pathological progression of cerebral ischemia/reperfusion (I/R) injury. Middle cerebral artery occlusion/reperfusion (MCAO/R) model was utilized in C57BL/6L mice to mimic ischemic stroke in vivo . Using oxygen-glucose deprivation and reoxygenation (ODG/R) model in microglia cells (BV-2) to establish cerebral I/R injury in vitro. Various methods, including Nogo-B siRNA transfection, mNSS and the rotarod test, TTC, HE and Nissl staining, immunofluorescence staining, immunohistochemistry, Western blot, ELISA, TUNEL and qRT-PCR were employed to probe into the effect of Nogo-B downregulation on cerebral I/R injury and the potential mechanisms. A small amount of Nogo-B expression (protein and mRNA) was observed in cortex and hippocampus before ischemia, then Nogo-B expression increased significantly on day 1, reaching the maximum on day 3, remaining stable on day 14 after I/R, and decreasing gradually after 21 days, but it still rose significantly compared with that observed preischemia. Nogo-B down-regulation could markedly reduce the neurological score and infarct volume, improve the histopathological changes and neuronal apoptosis, lower the number of CD86 + /Iba1 + cells and the levels of IL-1β, IL-6, and TNF-α, and raise the density of NeuN fluorescence, the number of CD206 + /Iba1 + cells, and the level of IL-4, IL-10 and TGF-β in brain of MCAO/R mice. Treatment with Nogo-B siRNA or TAK-242 in BV-2 cells could obviously decrease the CD86 fluorescence density and the mRNA expression of IL-1β, IL-6 and TNF-α, increase CD206 fluorescence density and the mRNA expression of IL-10 after OGD/R injury. In addition, the expression of TLR4, p-IκBα and p-p65 proteins significantly increased in the brain after MCAO/R and BV-2 cells exposed to OGD/R. Treatment with Nogo-B siRNA or TAK-242 prominently reduced the expression of TLR4, p-IκBα and p-p65. Our findings suggest that the down-regulation of Nogo-B exerts protective effect on cerebral I/R injury by modulating the microglia polarization through inhibiting TLR4/NF-κB signaling pathway. Nogo-B may be a potential therapeutic target for ischemic stroke.

The Nogo/Nogo Receptor (ngr) Signal is Involved in Neuroinflammation Through the Regulation of Microglial Inflammatory Activation.

Nogo‐66 Inhibits Adhesion and Migration of Microglia Via GTPase Rho Pathway in Vitro

The NLRP3 Inflammasome is Involved in Resident Intruder Paradigm-Induced Aggressive Behaviors in Mice

Identification of a New Functional Domain of Nogo‐A That Promotes Inflammatory Pain and Inhibits Neurite Growth Through Binding to NgR1

Expression of Nogo receptor 1 in microglia during development and following traumatic brain injury

Nogo-A promotes inflammatory heat hyperalgesia by maintaining TRPV-1 function in the rat dorsal root ganglion neuron.

Microglial Nogo delays recovery following traumatic brain injury in mice

NOGO-A INHIBITS ADHESION AND MIGRATION OF MICROGLIA TO AB IN VITRO

Nogo Receptor 3, a Paralog of Nogo-66 Receptor 1 (ngr1), May Function As a NgR1 Co-Receptor for Nogo-66

Downregulation of Nogo-B ameliorates cerebral ischemia/reperfusion injury in mice through regulating microglia polarization via TLR4/NF-kappaB pathway

IL-1β and TNF-α induce neurotoxicity through glutamate production: a potential role for neuronal glutaminase.

Nogo receptor impairs the clearance of fibril amyloid- by microglia and accelerates Alzheimer's-like disease progression

Interferon Regulatory Factor 5 Mediates Lipopolysaccharide-Induced Neuroinflammation

Intraneuronal localization of Nogo-A in the rat.

Nogo-p4 Suppresses TrkA Signaling Induced by Low Concentrations of Nerve Growth Factor Through NgR1 in Differentiated PC12 Cells

Long Noncoding RNA SNHG1 Promotes Lipopolysaccharide-Induced Activation and Inflammation in Microglia Via Targeting Mir-181B

Nogo receptor—a promising target for drug development

Regulation of proinflammatory cytokines gene expression by nociceptin/orphanin FQ in the spinal cord and the cultured astrocytes.

The Blockage of the Nogo/NgR Signal Pathway in Microglia Alleviates the Formation of Aβ Plaques and Tau Phosphorylation in APP/PS1 Transgenic Mice

NG2 expression in microglial cells affects the expression of neurotrophic and proinflammatory factors by regulating FAK phosphorylation

Nogo Enhances the Adhesion of Olfactory Ensheathing Cells and Inhibits Their Migration